HK1150620A1 - Docetaxel polymer derivative, method for producing same and use of same - Google Patents

Docetaxel polymer derivative, method for producing same and use of same

Info

Publication number
HK1150620A1
HK1150620A1 HK11104591.2A HK11104591A HK1150620A1 HK 1150620 A1 HK1150620 A1 HK 1150620A1 HK 11104591 A HK11104591 A HK 11104591A HK 1150620 A1 HK1150620 A1 HK 1150620A1
Authority
HK
Hong Kong
Prior art keywords
same
polymer derivative
docetaxel polymer
producing
producing same
Prior art date
Application number
HK11104591.2A
Other languages
English (en)
Inventor
Mitsunori Harada
Hiroyuki Saito
Yasuki Kato
Original Assignee
Nanocarrier Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocarrier Co Ltd filed Critical Nanocarrier Co Ltd
Publication of HK1150620A1 publication Critical patent/HK1150620A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/40—Polyamides containing oxygen in the form of ether groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
HK11104591.2A 2008-05-23 2011-05-09 Docetaxel polymer derivative, method for producing same and use of same HK1150620A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008135933 2008-05-23
JP2009060129 2009-03-12
PCT/JP2009/059633 WO2009142326A1 (ja) 2008-05-23 2009-05-20 ドセタキセル高分子誘導体、並びにその製造方法及びその用途

Publications (1)

Publication Number Publication Date
HK1150620A1 true HK1150620A1 (en) 2012-01-06

Family

ID=41340250

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104591.2A HK1150620A1 (en) 2008-05-23 2011-05-09 Docetaxel polymer derivative, method for producing same and use of same

Country Status (12)

Country Link
US (1) US20110136990A1 (xx)
EP (1) EP2287230B1 (xx)
JP (1) JP5037684B2 (xx)
KR (1) KR20110020779A (xx)
CN (1) CN102037058B (xx)
AU (1) AU2009250393B2 (xx)
CA (1) CA2724821A1 (xx)
DK (1) DK2287230T3 (xx)
ES (1) ES2396134T3 (xx)
HK (1) HK1150620A1 (xx)
TW (1) TW201008582A (xx)
WO (1) WO2009142326A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1792927B1 (en) * 2004-09-22 2013-03-06 Nippon Kayaku Kabushiki Kaisha Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
RU2447095C2 (ru) * 2006-05-18 2012-04-10 Ниппон Каяку Кабусики Кайся Высокомолекулярный конъюгат подофиллотоксинов
US8703878B2 (en) 2007-09-28 2014-04-22 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of steroids
WO2009116509A1 (ja) * 2008-03-18 2009-09-24 日本化薬株式会社 生理活性物質の高分子結合体
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
CN102421827B (zh) 2009-05-15 2014-07-30 日本化药株式会社 具有羟基的生理活性物质的高分子结合体
CN103221054A (zh) 2010-11-17 2013-07-24 日本化药株式会社 新的胞苷类代谢拮抗剂的高分子衍生物
WO2012135831A1 (en) 2011-04-01 2012-10-04 Yale University Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repair
EP2754682B1 (en) 2011-09-11 2017-06-07 Nippon Kayaku Kabushiki Kaisha Method for manufacturing block copolymer
MX2015015334A (es) 2013-05-17 2016-03-04 Nanocarrier Co Ltd Composicion farmaceutica de micela polimerica.
WO2017170845A1 (ja) * 2016-03-30 2017-10-05 ナノキャリア株式会社 薬物複合化ブロック共重合体、ブロック共重合体、および薬物複合化ブロック共重合体の製造方法
CN109803687B (zh) 2016-06-15 2022-11-15 耶鲁大学 纳米载体向肿瘤的抗体介导的自催化靶向递送
US20190330317A1 (en) 2016-06-15 2019-10-31 Yale University Anti-guanosine antibody as a molecular delivery vehicle
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
WO2023056450A1 (en) 2021-09-30 2023-04-06 Yale University Compositions and methods for the treatment of autosomal dominant polycystic kidney disease and other diseases having upregulated mtor activity
WO2024050524A1 (en) 2022-09-01 2024-03-07 University Of Georgia Research Foundation, Inc. Compositions and methods for directing apolipoprotein l1 to induce mammalian cell death

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517760B2 (ja) 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
JP2694923B2 (ja) * 1995-08-21 1997-12-24 科学技術振興事業団 水溶性高分子化医薬製剤
JP3523821B2 (ja) 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
KR100924990B1 (ko) * 2001-06-20 2009-11-04 니폰 가야꾸 가부시끼가이샤 불순물 함량을 감소시킨 블록 공중합체, 고분자 담체 및고분자 의약제제 및 그 제조 방법
EP1415648B1 (en) * 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
JP2003342168A (ja) * 2002-05-24 2003-12-03 Nano Career Kk 注射用薬物含有ポリマーミセル製剤の製造方法
US7495099B2 (en) 2002-10-31 2009-02-24 Nippon Kayaku Kabushiki Kaisha High-molecular weight derivatives of camptothecins
JP4757633B2 (ja) 2003-03-20 2011-08-24 日本化薬株式会社 難水溶性抗癌剤と新規ブロック共重合体を含むミセル調製物
WO2005079861A2 (en) * 2004-02-13 2005-09-01 Safeway Investments Ltd. Polymeric water soluble prodrugs
JP5249016B2 (ja) * 2006-03-28 2013-07-31 日本化薬株式会社 タキサン類の高分子結合体

Also Published As

Publication number Publication date
ES2396134T3 (es) 2013-02-19
AU2009250393A1 (en) 2009-11-26
KR20110020779A (ko) 2011-03-03
US20110136990A1 (en) 2011-06-09
EP2287230B1 (en) 2012-09-26
DK2287230T3 (da) 2012-12-10
EP2287230A1 (en) 2011-02-23
CN102037058B (zh) 2013-08-07
JPWO2009142326A1 (ja) 2011-09-29
JP5037684B2 (ja) 2012-10-03
CA2724821A1 (en) 2009-11-26
AU2009250393B2 (en) 2013-09-19
EP2287230A4 (en) 2011-11-23
TW201008582A (en) 2010-03-01
CN102037058A (zh) 2011-04-27
WO2009142326A1 (ja) 2009-11-26

Similar Documents

Publication Publication Date Title
HK1150620A1 (en) Docetaxel polymer derivative, method for producing same and use of same
EP2308932A4 (en) PROCESS FOR PRODUCING COLORING POLYMER, COLORING POLYMER, AND USE THEREOF
PL2080736T3 (pl) Aerożele węglowe, sposób ich wytwarzania i ich zastosowanie
EP2251081A4 (en) CATALYST, PROCESS FOR ITS MANUFACTURE AND USE
EP2270067A4 (en) POLYAMIDE, POLYAMIDE COMPOSITION AND METHOD FOR THE PREPARATION OF POLYAMIDE
EP2436702A4 (en) ISOBUTYLENE-BASED POLYMER AND METHOD FOR THE PRODUCTION THEREOF
EP2345685A4 (en) POLYMER AND METHOD FOR PREPARING THE SAME
EP2452673A4 (en) CHITOSAN GEL FOR DERMATOLOGICAL APPLICATIONS, METHOD FOR OBTAINING AND USING THE SAME
EP2428268A4 (en) CATALYST, PRODUCTION METHOD THEREFOR, AND USE THEREOF
EP2247623A4 (en) NEW CELLULOSE DERIVATIVES, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
EP2238451A4 (en) NANOSTRUCTURES, METHODS OF PREPARATION AND USES THEREOF
EP2299452A4 (en) Microstructure, and method for production thereof
PL2261014T3 (pl) Urządzenie formujące, jego klocek oraz sposób formowania
EP2471475A4 (en) CANNULA AND METHOD FOR PRODUCING THE SAME
EP2243725A4 (en) PACKAGING AND METHOD FOR THE PRODUCTION THEREOF
EP2612959A4 (en) HIGHLY BIODEGRADABLE AND BIOCOMPATIBLE NANOFIBRE AND PROCESS FOR PRODUCING THE SAME
GB2452134B (en) Method of producing fluoroapatite, fluoroapatite, and adsorption apparatus
EP2269981A4 (en) VINYL SULPHONIC ACID, POLYMER, AND METHOD OF PREPARING THEREOF
EP2116172A4 (en) DEVICE FOR TESTING FOR LUMEN PASSAGES, METHOD FOR TESTING FOR LUMEN PASSAGES AND METHOD FOR PRODUCING THE DEVICE FOR TESTING FOR LUMEN PASSAGES
GB0800570D0 (en) Composition, process for preparation and method of use
EP2412350A4 (en) BUFFER, BUFFER PRODUCTION METHOD, AND BUFFER PRODUCTION APPARATUS
EP2305649A4 (en) PROCESS FOR PREPARING A 6-ARYLOXYCHINOLINE DERIVATIVE AND INTERMEDIATE PRODUCT THEREOF
EP2607425A4 (en) METHOD FOR PRODUCING A CARBOXYL-CONTAINING POLYMER COMPOSITION AND CARBOXYL-CONTAINING POLYMER COMPOSITION
EP2346684A4 (en) POLYMER FABRIC, METHOD FOR PRODUCING THE SAME, AND USE THEREOF
GB0818563D0 (en) Polymer composite and method for its manufacture

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160520